ArticlePlant methods2025
pSIG plasmids, MoClo-compatible vectors for efficient production of chimeric double-stranded RNAs in Escherichia coli HT115 (DE3) strain.
Article in Plant methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Genetic Biosensor for Optimizing Double-Stranded RNA Production by Bacteria.ACS synthetic biology · 2026Article
- Molecular Identification and RNA-Based Management of Fungal Plant Pathogens: From PCR to CRISPR/Cas9.International journal of molecular sciences · 2026Review
- Regulation ofFrontiers in insect science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSpray-induced gene silencing (SIGS) is a promising strategy for controlling plant diseases caused by pests, fungi, and viruses. The method involves spraying on plant surfaces double-stranded RNAs (dsRNAs) that target pathogen genes and inhibit pathogen growth via activation of the RNA interference machinery. Despite its potential, significant challenges remain in the application of SIGS, including producing large quantities of dsRNAs for field applications. While industrial-scale dsRNA production is feasible, most research laboratories still rely on costly and labor-intensive in vitro transcription kits that are difficult to scale up for field trials. Therefore, there is a critical need for highly efficient and scalable methods for producing diverse dsRNAs in research laboratories.
resultsThis study introduces pSIG plasmids, MoClo-compatible vectors designed for efficient dsRNA production in the Escherichia coli RNase III-deficient strain HT115 (DE3). The pSIG vectors enable the assembly of multiple DNA fragments in a single reaction using highly efficient Golden Gate cloning, thereby allowing the production of chimeric dsRNAs to simultaneously silence multiple genes in target pests and pathogens. To demonstrate the efficacy of this system, we generated 12 dsRNAs targeting essential genes in Botrytis cinerea. The results revealed that silencing the Bcerg1, Bcerg2, and Bcerg27 genes involved in the ergosterol biosynthesis pathway, significantly reduced fungal infection in plant leaves. Furthermore, we synthesized a chimeric dsRNA, Bcergi, that incorporates target fragments from Bcerg1, Bcerg2, and Bcerg27. Nevertheless, the Bcerg1 dsRNA alone achieved greater disease suppression than the chimeric Bcergi dsRNA.
conclusionsHere, we developed a highly efficient and scalable method for producing chimeric dsRNAs in E. coli HT115 (DE3) in research laboratories using our homemade pSIG plasmid vectors. This approach addresses key challenges in SIGS research, including the need to produce large quantities of dsRNA and identify effective dsRNAs, thus enhancing the feasibility of SIGS as a sustainable strategy for controlling plant diseases and pests in crops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.